Bill:  SB 241 
Legislative Session: 88(R) Author: Perry
Add to Bill List
Introduced
Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability.

Senate Committee Report
Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability.

Engrossed
Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability.

House Committee Report
Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability.

Enrolled
Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability.